Center of Clinical Investigations in Biotherapies of Cancer (CICBT)

France

1 May 2020 - 1 April 2021

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Center of Clinical Investigations in Biotherapies of Cancer (CICBT) published between 1 May 2020 - 1 April 2021 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Research collaboration: Center of Clinical Investigations in Biotherapies of Cancer (CICBT) is a research collaboration whose article contributions are accrued to its participating partner institutions.

Note: Articles may be assigned to more than one subject area.

Count Share
4 0.21

Outputs by subject (Share)

Subject Count Share
Life Sciences 4 0.21

1 May 2020 - 1 April 2021

International vs. domestic collaboration by Share

  • 85.64% Domestic
  • 14.36% International

Note: Hover over the graph to view the percentage of collaboration.

Top 10 domestic collaborators by Share (55 total)

  • Center of Clinical Investigations in Biotherapies of Cancer (CICBT), France
  • Domestic institution
  1. Institute Gustave-Roussy (IGR), France (1.18)
    0.21
    0.97
  2. Immunity and Cancer Unit, France (0.71)
    0.17
    0.53
  3. National Institute for Health and Medical Research (INSERM), France (0.67)
    0.21
    0.46
  4. Curie Institute, France (0.64)
    0.21
    0.43
  5. University of Paris, France (0.50)
    0.21
    0.29
  6. Assistance Publique-Hôpitaux de Paris (AP-HP), France (0.49)
    0.21
    0.28
  7. French National Centre for Scientific Research (CNRS), France (0.33)
    0.21
    0.12
  8. Tumour Immunology and Anti-Cancer Immunotherapy Unit, France (0.32)
    0.04
    0.28
  9. Cordelier Research Center (CRC), France (0.32)
    0.03
    0.29
  10. Imagine Institute, France (0.22)
    0.17
    0.05

Top 10 international collaborators by Share (22 total)

  • Center of Clinical Investigations in Biotherapies of Cancer (CICBT), France
  • Foreign institution
  1. University of Zurich (UZH), Switzerland (0.27)
    0.17
    0.10
  2. Cornell University, United States of America (USA) (0.20)
    0.01
    0.19
  3. University of Erlangen-Nuremberg (FAU), Germany (0.09)
    0.02
    0.07
  4. Martin Luther University Halle-Wittenberg (MLU), Germany (0.08)
    0.01
    0.07
  5. Caryl and Israel Englander Institute for Precision Medicine (IPM), Cornell University, United States of America (USA) (0.07)
    0.01
    0.06
  6. Sotio, a.s., Czech Republic (0.06)
    0.01
    0.06
  7. Ghent University (UGent), Belgium (0.06)
    0.02
    0.04
  8. Charles University (CU), Czech Republic (0.05)
    0.01
    0.04
  9. Flanders Institute for Biotechnology (VIB), Belgium (0.05)
    0.02
    0.03
  10. Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), China (0.04)
    0.03
    0.01

Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.

Center of Clinical Investigations in Biotherapies of Cancer (CICBT)

Participating institutions

Center of Clinical Investigations in Biotherapies of Cancer (CICBT) is a research collaboration whose article contributions are accrued to its participating partner institutions below.

Creative Commons License

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Return to institution outputs

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER